You are here: Industry Insights > Verdict

News List

Environmental sustainability in the pharmaceutical industry needs to be addressed the most: poll pharmaceutical-technology
February 20, 2021
As resource consumption grows, several industries including the pharmaceutical industry are under pressure to implement sustainable practices.
Telemedicine to benefit the most from remote patient monitoring tools: Poll pharmaceutical-technology
January 26, 2021
The COVID-19 pandemic has led to a surge in the use of remote patient monitoring (RPM) tools to monitor patients outside the standard healthcare settings.
Business optimism improves in December amid COVID-19 vaccine rollout: Poll pharmaceutical-technology
January 11, 2021
Emerging economies are projected to benefit the most from vaccine rollout, which is expected to differ between countries. While some countries may be able to effectively administrate vaccines, others may fall short of inoculating roughly 30% of their popu
COVID-19 poll: Disrupted clinical trials will take six to 12 months to return to normal pharmaceutical-technology
August 06, 2020
The COVID-19 pandemic significantly disrupted ongoing clinical trials in various stages, with more than 1,000 trials by sponsors, collaborators, or contract research organisations having gone off the trial schedules.
Improved patient access seen as the main benefit of telemedicine: Poll pharmaceutical-technology
August 06, 2020
Regulatory and privacy concerns have hindered the adoption of telemedicine despite the service existing for a while. The COVID-19 pandemic, however, resulted in significant uptake of telemedicine services.
Reimbursement of telemedicine services could continue even after the abatement of COVID-19 pandemic: Poll pharmaceutical-technology
July 21, 2020
Telemedicine services are being adopted widely by healthcare providers during the COVID-19 pandemic to continue providing services and avoid further surge in infection rate.
Approved COVID-19 vaccine could be available in six months; high-risk groups should get priority access: Poll pharmaceutical-technolog
July 13, 2020
The global spread of the COVID-19 pandemic and the resulting economic impact and public health burden has highlighted the urgent need for a vaccine to prevent the disease.
COVID-19 vaccine could be approved and available to public within six months: Poll pharmaceutical-technology
July 03, 2020
The global spread of the COVID-19 pandemic and the resulting economic impact and public health burden has highlighted the urgent need for a vaccine to prevent the disease.
Lack of awareness among patients the biggest challenge to wider adoption of telemedicine: Poll pharmaceutical-technology
April 23, 2020
Telemedicine has witnessed an increased usage during the COVID-19 pandemic but challenges remain for its widespread adoption.
Are companies optimistic about growth prospects following COVID-19 stimulus measures? pharmaceutical-technology
April 17, 2020
The COVID-19 outbreak has marred the growth expectations of companies of all sizes globally, across multiple industries.

Previous page 1 2 3 Next page